Please read Case study 5.2 and answer the questions at the end about the caseDISCUSSION QUESTIONS1. What explains the high price of prescription medicines in the United States? What if anything should be done about it? Do you believe that in the United States drug prices reflect the operation of a fair and competitive market?2. Given the nature of their product, do pharmaceutical companies have ethical responsibilities that other corporations don’t have? In your view, are the large U.S. drug companies good corporate citizens?3. Are the large drug companies guilty of price gouging or of charging an unfair or exploitative price for their products? Should Americans be permitted to import drugs from Canada or other countries?4. Assess the motivations of drug companies that do their testing overseas. Do you think test subjects are being exploited or taken advantage of? Under what circumstances, if any, are companies morally justified in testing overseas?5. Do drug companies have an obligation to make new drugs available to patients who were involved in their development, either here or overseas? Does the size of the company make a difference? What would you do if you were Dr. Lange? What obligations, ideals, and consequences should he take into account?6. Is it ethical for companies to decline to sell a useful drug like ranolazine in a poor country because they can make more money marketing it elsewhere?7. When it comes to life-saving drugs, do pharmaceuti-cal companies have a moral obligation to make them available in poor countries at little or no cost? Explain why or why not. What about effective but non-life-saving drugs like ranolazine?